Measurements
Cancer
BLOOD, CANCER
The baseline assessment included blood tests, enhanced abdominopelvic computed tomography (APCT), hand grip strength, 6-m universal gait speed, and bioelectrical impedance analysis (InBody) and was performed before the EIP. Blood tests, including hemoglobin (Hb), total leukocytes count (TLC), albumin, prealbumin, transferrin, and c-reactive protein (CRP), were conducted at 6 and 12 weeks during the EIP. In addition, the APCT, handgrip strength, 6-m universal gait speed, and InBody measurements were evaluated at 6 and 12 weeks during the EIP.The EIP was performed during the six weeks of palliative chemotherapy. Before the EIP, the rehabilitation department evaluated the exercise ability as a baseline assessment to confirm the exercise performance ability and measured the effectiveness variable for comparison after six weeks. The patient performed the EIP for six weeks. If the patient experienced no problems, the EIP was extended for 12 weeks, and the EIP was continuously evaluated for an additional second evaluation.Quality of life was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ C30). The EORTC-QLQ C30 was given to patients as a baseline before the EIP, at 6 weeks after the EIP, and at 12 weeks after the EIP.